Tissue Factor in Cardiovascular Disease. Pathophysiology and Pharmacological Intervention

Advances in Pharmacology

Volumn 59, Issue C, 2010, Pages 259-292

  Holy, Erik W ^a,b   Tanner, Felix C ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

AsTF; Cardiovascular disease; Egr 1; ERK; JNK; LPS; MAPK; PAR; PDGF; PI3K; PPAR; RNAPc2; TF; Thrombosis; Tissue factor; TNF ; VEGF

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTISENSE OLIGONUCLEOTIDE; CLOPIDOGREL; DIGOXIN; DIMETHYL SULFOXIDE; EPIGALLOCATECHIN GALLATE; GUGGULSTERONE; HEPARIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CNTO 859; MONOCLONAL ANTIBODY SUNOL CH36 ALT 836; OUABAIN; RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN C2; RECOMBINANT PROTEIN; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR; FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLEEDING; BOOK; BREAST CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPLEX FORMATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; INFLAMMATION; METASTASIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; THROMBOSIS; THROMBUS; ANIMAL; BLOOD; BLOOD CLOTTING; CHEMISTRY; PHYSIOLOGY; REVIEW;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CARDIOVASCULAR DISEASES; FIBRINOLYTIC AGENTS; HUMANS; THROMBOPLASTIN;

EID: 78049491325     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(10)59009-4     Document Type: Chapter

References (206)

1. Abdulkadir S.A., Carvalhal G.F., Kaleem Z., Kisiel W., Humphrey P.A., Catalona W.J., et al. Tissue factor expression and angiogenesis in human prostate carcinoma. Human Pathology 2000, 31(4):443-447.
2. Abe K., Shoji M., Chen J., Bierhaus A., Danave I., Micko C., et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(15):8663-8668.
3. Abid Hussein M.N., Meesters E.W., Osmanovic N., Romijn F.P., Nieuwland R., Sturk A. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. Journal of Thrombosis and Haemostasis 2003, 1(11):2434-2443.
4. Abraham E., Reinhart K., Opal S., Demeyer I., Doig C., Rodriguez A.L., et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. The Journal of the American Medical Association 2003, 290(2):238-247.
5. Annex B.H., Denning S.M., Channon K.M., Sketch M.H., Stack R.S., Morrissey J.H., et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995, 91(3):619-622.
6. Aras O., Shet A., Bach R.R., Hysjulien J.L., Slungaard A., Hebbel R.P., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004, 103(12):4545-4553.
7. Ardissino D., Merlini P.A., Ariens R., Coppola R., Bramucci E., Mannucci P.M. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet 1997, 349(9054):769-771.
8. Badimon J.J., Lettino M., Toschi V., Fuster V., Berrozpe M., Chesebro J.H., et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 1999, 99(14):1780-1787.
9. Bavendiek U., Libby P., Kilbride M., Reynolds R., Mackman N., Schonbeck U. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. The Journal of Biological Chemistry 2002, 277(28):25032-25039.
10. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(18):6934-6938.
11. Bea F., Blessing E., Shelley M.I., Shultz J.M., Rosenfeld M.E. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: Potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Atherosclerosis 2003, 167(2):187-194.
12. Belting M., Dorrell M.I., Sandgren S., Aguilar E., Ahamed J., Dorfleutner A., et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nature Medicine 2004, 10(5):502-509.
13. Bergum P.W., Cruikshank A., Maki S.L., Kelly C.R., Ruf W., Vlasuk G.P. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. The Journal of Biological Chemistry 2001, 276(13):10063-10071.
14. Bierhaus A., Chevion S., Chevion M., Hofmann M., Quehenberger P., Illmer T., et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997, 46(9):1481-1490.
15. Bierhaus A., Illmer T., Kasper M., Luther T., Quehenberger P., Tritschler H., et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 1997, 96(7):2262-2271.
16. Biro E., Sturk-Maquelin K.N., Vogel G.M., Meuleman D.G., Smit M.J., Hack C.E., et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. Journal of Thrombosis and Haemostasis 2003, 1(12):2561-2568.
17. Blum S., Issbruker K., Willuweit A., Hehlgans S., Lucerna M., Mechtcheriakova D., et al. An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression. The Journal of Biological Chemistry 2001, 276(36):33428-33434.
18. Boeri D., Almus F.E., Maiello M., Cagliero E., Rao L.V., Lorenzi M. Modification of tissue-factor mRNA and protein response to thrombin and interleukin 1 by high glucose in cultured human endothelial cells. Diabetes 1989, 38(2):212-218.
19. Bogdanov V.Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., Nemerson Y. Alternatively spliced human tissue factor: A circulating, soluble, thrombogenic protein. Nature Medicine 2003, 9(4):458-462.
20. Bogdanov V.Y., Kirk R.I., Miller C., Hathcock J.J., Vele S., Gazdoiu M., et al. Identification and characterization of murine alternatively spliced tissue factor. Journal of Thrombosis and Haemostasis 2006, 4(1):158-167.
21. Brand K., Fowler B.J., Edgington T.S., Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Molecular and Cellular Biology 1991, 11(9):4732-4738.
22. Brandes R.P., Beer S., Ha T., Busse R. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23(10):1794-1800.
23. Breitenstein A., Camici G.G., Tanner F.C. Tissue factor: Beyond coagulation in the cardiovascular system. Clinical Science (London) 2010, 118(3):159-172.
24. Breitenstein A., Stampfli S.F., Camici G.G., Akhmedov A., Ha H.R., Follath F., et al. Amiodarone inhibits arterial thrombus formation and tissue factor translation. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28(12):2231-2238.
25. Breitenstein A., Tanner F.C., Luscher T.F. Tissue factor and cardiovascular disease: Quo vadis?. Circulation Journal 2010, 74(1):3-12.
26. Bromberg M.E., Konigsberg W.H., Madison J.F., Pawashe A., Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(18):8205-8209.
27. Bromberg M.E., Sundaram R., Homer R.J., Garen A., Konigsberg W.H. Role of tissue factor in metastasis: Functions of the cytoplasmic and extracellular domains of the molecule. Thrombosis and Haemostasis 1999, 82(1):88-92.
28. Broze G.J., Leykam J.E., Schwartz B.D., Miletich J.P. Purification of human brain tissue factor. The Journal of Biological Chemistry 1985, 260(20):10917-10920.
29. Brunetti N.D., Munno I., Pellegrino P.L., Ruggiero V., Correale M., Cuculo A., et al. Inflammatory cytokine imbalance after coronary angioplasty: Links with coronary atherosclerosis. Journal of Interventional Cardiology 2007, 20(4):248-257.
30. Butenas S., Bouchard B.A., Brummel-Ziedins K.E., Parhami-Seren B., Mann K.G. Tissue factor activity in whole blood. Blood 2005, 105(7):2764-2770.
31. Cai H., Song C., Endoh I., Goyette J., Jessup W., Freedman S.B., et al. Serum amyloid A induces monocyte tissue factor. Journal of Immunology 2007, 178(3):1852-1860.
32. Camera M., Frigerio M., Toschi V., Brambilla M., Rossi F., Cottell D.C., et al. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23(9):1690-1696.
33. Camera M., Giesen P.L., Fallon J., Aufiero B.M., Taubman M., Tremoli E., et al. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 1999, 19(3):531-537.
34. Camerer E., Gjernes E., Wiiger M., Pringle S., Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. The Journal of Biological Chemistry 2000, 275(9):6580-6585.
35. Camerer E., Rottingen J.A., Gjernes E., Larsen K., Skartlien A.H., Iversen J.G., et al. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. The Journal of Biological Chemistry 1999, 274(45):32225-32233.
36. 2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. The Journal of Biological Chemistry 1996, 271(46):29034-29042.
37. Camici G.G., Steffel J., Akhmedov A., Schafer N., Baldinger J., Schulz U., et al. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: A potential treatment strategy for drug-eluting stents. Circulation 2006, 114(14):1512-1521.
38. Camici G.G., Steffel J., Amanovic I., Breitenstein A., Baldinger J., Keller S., et al. Rapamycin promotes arterial thrombosis in vivo: Implications for everolimus and zotarolimus eluting stents. European Heart Journal 2010, 31(2):236-242.
39. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., et al. Role of tissue factor in embryonic blood vessel development. Nature 1996, 383(6595):73-75.
40. Cavusoglu E., Chen I., Rappaport J., Marmur J.D. Inhibition of tissue factor gene induction and activity using a hairpin ribozyme. Circulation 2002, 105(19):2282-2287.
41. Censarek P., Bobbe A., Grandoch M., Schror K., Weber A.A. Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thrombosis and Haemostasis 2007, 97(1):11-14.
42. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993, 82(2):513-520.
43. Chong A.J., Pohlman T.H., Hampton C.R., Shimamoto A., Mackman N., Verrier E.D. Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury. The Annals of Thoracic Surgery 2003, 75(2):S649-S655.
44. Chou J., Mackman N., Merrill-Skoloff G., Pedersen B., Furie B.C., Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004, 104(10):3190-3197.
45. Creasey A.A., Chang A.C., Feigen L., Wun T.C., Taylor F.B., Hinshaw L.B. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. The Journal of Clinical Investigation 1993, 91(6):2850-2860.
46. Cugno M., Marzano A.V., Tedeschi A., Fanoni D., Venegoni L., Asero R. Expression of tissue factor by eosinophils in patients with chronic urticaria. International Archives of Allergy and Immunology 2009, 148(2):170-174.
47. Day S.M., Reeve J.L., Pedersen B., Farris D.M., Myers D.D., Im M., et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005, 105(1):192-198.
48. Diamant M., Nieuwland R., Pablo R.F., Sturk A., Smit J.W., Radder J.K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002, 106(19):2442-2447.
49. Dielis A.W., Smid M., Spronk H.M., Hamulyak K., Kroon A.A., ten Cate H., et al. The prothrombotic paradox of hypertension: Role of the renin-angiotensin and kallikrein-kinin systems. Hypertension 2005, 46(6):1236-1242.
50. Drake T.A., Morrissey J.H., Edgington T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. The American Journal of Pathology 1989, 134(5):1087-1097.
51. Durrington P. Dyslipidaemia. Lancet 2003, 362(9385):717-731.
52. Edgington T.S., Ruf W., Rehemtulla A., Mackman N. The molecular biology of initiation of coagulation by tissue factor. Current Studies in Hematology and Blood Transfusion 1991, (58):15-21.
53. El-Ghoroury E.A., El-Din H.G., Abdel-Kader M., Ragab S. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus. Blood Coagulation and Fibrinolysis 2008, 19(1):7-13.
54. Erlich J.H., Boyle E.M., Labriola J., Kovacich J.C., Santucci R.A., Fearns C., et al. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. The American Journal of Pathology 2000, 157(6):1849-1862.
55. Eto M., Kouroedov A., Cosentino F., Luscher T.F. Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-alpha. Circulation 2005, 112(9):1316-1322.
56. Eto M., Kozai T., Cosentino F., Joch H., Luscher T.F. Statin prevents tissue factor expression in human endothelial cells: Role of Rho/Rho-kinase and Akt pathways. Circulation 2002, 105(15):1756-1759.
57. Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. The Journal of Experimental Medicine 2003, 197(11):1585-1598.
58. Fei H., Berliner J.A., Parhami F., Drake T.A. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arteriosclerosis, Thrombosis, and Vascular Biology 1993, 13(11):1711-1717.
59. Felmeden D.C., Spencer C.G., Chung N.A., Belgore F.M., Blann A.D., Beevers D.G., et al. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). The American Journal of Cardiology 2003, 92(4):400-405.
60. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Reviews 1997, 18(1):4-25.
61. Fleck R.A., Rao L.V., Rapaport S.I., Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thrombosis Research 1990, 59(2):421-437.
62. Fluture A., Giugliano G.R., Giugliano R.P. Recombinant nematode anticoagulant protein c2 in non-ST segment elevation acute coronary syndrome and beyond. Future Cardiology 2007, 3(4):365-375.
63. Fu Y., Zhang Z., Zhang G., Liu Y., Cao Y., Yu J., et al. Adenovirus-mediated gene transfer of tissue factor pathway inhibitor induces apoptosis in vascular smooth muscle cells. Apoptosis 2008, 13(5):634-640.
64. Gailani D., Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27(12):2507-2513.
65. Gebhard C., Stampfli S.F., Gebhard C.E., Akhmedov A., Breitenstein A., Camici G.G., et al. Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis. Basic Research in Cardiology 2009, 104(3):285-294.
66. Giugliano R.P., Wiviott S.D., Stone P.H., Simon D.I., Schweiger M.J., Bouchard A., et al. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: The ANTHEM-TIMI-32 trial. Journal of the American College of Cardiology 2007, 49(25):2398-2407.
67. Golledge J., Mangan S., Clancy P. Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas. Stroke 2007, 38(5):1501-1508.
68. Guba M., Yezhelyev M., Eichhorn M.E., Schmid G., Ischenko I., Papyan A., et al. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood 2005, 105(11):4463-4469.
69. Guha M., Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. The Journal of Biological Chemistry 2002, 277(35):32124-32132.
70. Hamuro T., Kamikubo Y., Nakahara Y., Miyamoto S., Funatsu A. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells. FEBS Letters 1998, 421(3):197-202.
71. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005, 352(16):1685-1695.
72. Harker L.A., Hanson S.R., Wilcox J.N., Kelly A.B. Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis 1996, 26(Suppl. 1):76-82.
73. Hartzell S., Ryder K., Lanahan A., Lau L.F., Nathan D. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Molecular and Cellular Biology 1989, 9(6):2567-2573.
74. Hathcock J.J., Nemerson Y. Platelet deposition inhibits tissue factor activity: In vitro clots are impermeable to factor Xa. Blood 2004, 104(1):123-127.
75. He Y., Chang G., Zhan S., Song X., Wang X., Luo Y. Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells. Biochemical and Biophysical Research Communications 2008, 370(3):489-494.
76. He M., He X., Xie Q., Chen F., He S. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. Thrombosis Research 2006, 117(5):579-590.
77. Himber J., Wohlgensinger C., Roux S., Damico L.A., Fallon J.T., Kirchhofer D., et al. Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. Journal of Thrombosis and Haemostasis 2003, 1(5):889-895.
78. Hoffman M., Whinna H.C., Monroe D.M. Circulating tissue factor accumulates in thrombi, but not in hemostatic plugs. Journal of Thrombosis and Haemostasis 2006, 4(9):2092-2093.
79. Holy E.W., Akhmedov A., Luscher T.F., Tanner F.C. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. Journal of Molecular and Cellular Cardiology 2009, 46(2):234-240.
80. Holy E.W., Stampfli S.F., Akhmedov A., Holm N., Camici G.G., Luscher T.F., et al. Laminin receptor activation inhibits endothelial tissue factor expression. Journal of Molecular and Cellular Cardiology 2009, 48(6):1138-1145.
81. Hron G., Kollars M., Weber H., Sagaster V., Quehenberger P., Eichinger S., et al. Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer. Thrombosis and Haemostasis 2007, 97(1):119-123.
82. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. The Journal of the American Medical Association 2005, 293(17):2126-2130.
83. Ikonomidis I., Athanassopoulos G., Lekakis J., Venetsanou K., Marinou M., Stamatelopoulos K., et al. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: A dobutamine stress echocardiography study. Circulation 2005, 112(21):3272-3279.
84. Israelian-Konaraki Z., Reaven P.D. Peroxisome proliferator-activated receptor-alpha and atherosclerosis: From basic mechanisms to clinical implications. Cardiology 2005, 103(1):1-9.
85. Jang Y., Guzman L.A., Lincoff A.M., Gottsauner-Wolf M., Forudi F., Hart C.E., et al. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 1995, 92(10):3041-3050.
86. Jedsadayanmata A., Chen C.C., Kireeva M.L., Lau L.F., Lam S.C. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). The Journal of Biological Chemistry 1999, 274(34):24321-24327.
87. Jesty J., Beltrami E. Positive feedbacks of coagulation: Their role in threshold regulation. Arteriosclerosis. Thrombosis, and Vascular Biology 2005, 25(12):2463-2469.
88. Jiao J.A., Kelly A.B., Marzec U.M., Nieves E., Acevedo J., Burkhardt M., et al. Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site. Thrombosis and Haemostasis 2010, 103(1):224-233.
89. Kambas K., Markiewski M.M., Pneumatikos I.A., Rafail S.S., Theodorou V., Konstantonis D., et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. Journal of Immunology 2008, 180(11):7368-7375.
90. Kamimura M., Bea F., Akizawa T., Katus H.A., Kreuzer J., Viedt C. Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1. Hypertension 2004, 44(6):944-951.
91. Kao F.T., Hartz J., Horton R., Nemerson Y., Carson S.D. Regional assignment of human tissue factor gene (F3) to chromosome 1p21-p22. Somatic Cell and Molecular Genetics 1988, 14(4):407-410.
92. Kislinger T., Tanji N., Wendt T., Qu W., Lu Y., Ferran L.J. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arteriosclerosis. Thrombosis, and Vascular Biology 2001, 21(6):905-910.
93. Koh K.K., Chung W.J., Ahn J.Y., Han S.H., Kang W.C., Seo Y.H., et al. Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: A randomized, double-blind, placebo-controlled study. Atherosclerosis 2004, 177(1):155-160.
94. Koomagi R., Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis. International Journal of Cancer 1998, 79(1):19-22.
95. Lalloyer F., Staels B. Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arteriosclerosis. Thrombosis, and Vascular Biology 2010, 30(5):894-899.
96. Lechner D., Kollars M., Gleiss A., Kyrle P.A., Weltermann A. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity. Journal of Thrombosis and Haemostasis 2007, 5(12):2445-2452.
97. Lee K.W., Blann A.D., Lip G.Y. Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes. Thrombosis and Haemostasis 2005, 94(5):1077-1083.
98. Lewis J.C., Bennett-Cain A.L., DeMars C.S., Doellgast G.J., Grant K.W., Jones N.L., et al. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. The American Journal of Pathology 1995, 147(4):1029-1040.
99. Lim H.S., Blann A.D., Lip G.Y. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: Relationships to cardiovascular disease and risk factor intervention. Circulation 2004, 109(21):2524-2528.
100. Llorente-Cortes V., Otero-Vinas M., Camino-Lopez S., Llampayas O., Badimon L. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 2004, 110(4):452-459.
101. Luyendyk J.P., Schabbauer G.A., Tencati M., Holscher T., Pawlinski R., Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. Journal of Immunology 2008, 180(6):4218-4226.
102. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor. Circulation 1997, 96(2):396-399.
103. Mackman N. Regulation of the tissue factor gene. Thrombosis and Haemostasis 1997, 78(1):747-754.
104. Mackman N. Alternatively spliced tissue factor-one cut too many?. Thrombosis and Haemostasis 2007, 97(1):5-8.
105. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesthesia and Analgesia 2009, 108(5):1447-1452.
106. Mackman N., Morrissey J.H., Fowler B., Edgington T.S. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 1989, 28(4):1755-1762.
107. Mackman N., Sawdey M.S., Keeton M.R., Loskutoff D.J. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. The American Journal of Pathology 1993, 143(1):76-84.
108. Mackman N., Tilley R.E., Key N.S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27(8):1687-1693.
109. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P.G., Freyssinet J.M., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000, 101(8):841-843.
110. Maragoudakis M.E., Tsopanoglou N.E., Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochemical Society Transactions 2002, 30(2):173-177.
111. Markle R.A., Han J., Summers B.D., Yokoyama T., Hajjar K.A., Hajjar D.P., et al. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. Journal of Cellular Biochemistry 2003, 90(1):23-32.
112. Marmur J.D., Thiruvikraman S.V., Fyfe B.S., Guha A., Sharma S.K., Ambrose J.A., et al. Identification of active tissue factor in human coronary atheroma. Circulation 1996, 94(6):1226-1232.
113. Marutsuka K., Hatakeyama K., Sato Y., Yamashita A., Sumiyoshi A., Asada Y. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thrombosis Research 2002, 107(5):271-276.
114. Marx N., Duez H., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors and atherogenesis: Regulators of gene expression in vascular cells. Circulation Research 2004, 94(9):1168-1178.
115. Marx N., Mackman N., Schonbeck U., Yilmaz N., Hombach V., Libby P., et al. PPARalpha activators inhibit tissue factor expression and activity in human monocytes. Circulation 2001, 103(2):213-219.
116. Matsumae H., Yoshida Y., Ono K., Togi K., Inoue K., Furukawa Y., et al. CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28(6):1077-1083.
117. Maugeri N., Brambilla M., Camera M., Carbone A., Tremoli E., Donati M.B., et al. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. Journal of Thrombosis and Haemostasis 2006, 4(6):1323-1330.
118. Maugeri N., Giordano G., Petrilli M.P., Fraticelli V., de Gaetano G., Cerletti C., et al. Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: A new effect for an old drug?. Journal of Thrombosis and Haemostasis 2006, 4(12):2593-2598.
119. Mechtcheriakova D., Schabbauer G., Lucerna M., Clauss M., De Martin R., Binder B.R., et al. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. The FASEB Journal 2001, 15(1):230-242.
120. Mechtcheriakova D., Wlachos A., Holzmuller H., Binder B.R., Hofer E. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 1999, 93(11):3811-3823.
121. Melis E., Moons L., De Mol M., Herbert J.M., Mackman N., Collen D., et al. Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development. Biochemical and Biophysical Research Communications 2001, 286(3):580-586.
122. Miller D.L., Welty-Wolf K., Carraway M.S., Ezban M., Ghio A., Suliman H., et al. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. American Journal of Respiratory Cell and Molecular Biology 2002, 26(6):650-658.
123. Misumi K., Ogawa H., Yasue H., Soejima H., Suefuji H., Nishiyama K., et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. The American Journal of Cardiology 1998, 81(1):22-26.
124. Monetti M., Canavesi M., Camera M., Parente R., Paoletti R., Tremoli E., et al. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. Pharmacological Research 2007, 55(5):441-449.
125. Moons A.H., Peters R.J., Bijsterveld N.R., Piek J.J., Prins M.H., Vlasuk G.P., et al. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty. Journal of the American College of Cardiology 2003, 41(12):2147-2153.
126. Moosbauer C., Morgenstern E., Cuvelier S.L., Manukyan D., Bidzhekov K., Albrecht S., et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 2007, 109(3):995-1002.
127. Morrissey J.H., Gregory S.A., Mackman N., Edgington T.S. Tissue factor regulation and gene organization. Oxford Surveys on Eukaryotic Genes 1989, 6:67-84.
128. Morrow D.A., Murphy S.A., McCabe C.H., Mackman N., Wong H.C., Antman E.M. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): Results of the PROXIMATE-TIMI 27 trial. European Heart Journal 2005, 26(7):682-688.
129. Mueller B.M., Reisfeld R.A., Edgington T.S., Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(24):11832-11836.
130. Mueller B.M., Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. The Journal of Clinical Investigation 1998, 101(7):1372-1378.
131. Muller I., Klocke A., Alex M., Kotzsch M., Luther T., Morgenstern E., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. The FASEB Journal 2003, 17(3):476-478.
132. Napoleone E., Di Santo A., Camera M., Tremoli E., Lorenzet R. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circulation Research 2000, 86(2):139-143.
133. Napoleone E., Di Santo A., Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: A role for cell-cell contact and cross-talk. Blood 1997, 89(2):541-549.
134. Ngo C.V., Picha K., McCabe F., Millar H., Tawadros R., Tam S.H., et al. CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. International Journal of Cancer 2007, 120(6):1261-1267.
135. Nishida T., Ueno H., Atsuchi N., Kawano R., Asada Y., Nakahara Y., et al. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit. Circulation Research 1999, 84(12):1446-1452.
136. Oemar B.S., Luscher T.F. Connective tissue growth factor. Friend or foe?. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17(8):1483-1489.
137. Oemar B.S., Werner A., Garnier J.M., Do D.D., Godoy N., Nauck M., et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997, 95(4):831-839.
138. Okorie U.M., Denney W.S., Chatterjee M.S., Neeves K.B., Diamond S.L. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: Amplification of 100 fM circulating tissue factor requires flow. Blood 2008, 111(7):3507-3513.
139. Orfeo T., Butenas S., Brummel-Ziedins K.E., Mann K.G. The tissue factor requirement in blood coagulation. The Journal of Biological Chemistry 2005, 280(52):42887-42896.
140. Osterud B., Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Seminars in Thrombosis and Hemostatis 2001, 27(6):605-617.
141. Ott I., Fischer E.G., Miyagi Y., Mueller B.M., Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. Journal of Cellular Biology 1998, 140(5):1241-1253.
142. Ott I., Michaelis C., Schuermann M., Steppich B., Seitz I., Dewerchin M., et al. Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor. Circulation Research 2005, 97(3):293-298.
143. Paborsky L.R., Caras I.W., Fisher K.L., Gorman C.M. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. The Journal of Biological Chemistry 1991, 266(32):21911-21916.
144. Panes O., Matus V., Saez C.G., Quiroga T., Pereira J., Mezzano D. Human platelets synthesize and express functional tissue factor. Blood 2007, 109(12):5242-5250.
145. Pawlinski R., Fernandes A., Kehrle B., Pedersen B., Parry G., Erlich J., et al. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(24):15333-15338.
146. Pawlinski R., Mackman N. Cellular sources of tissue factor in endotoxemia and sepsis. Thrombosis Research 2010, 125(Suppl. 1):S70-S73.
147. Pawlinski R., Pedersen B., Schabbauer G., Tencati M., Holscher T., Boisvert W., et al. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004, 103(4):1342-1347.
148. Pawlinski R., Wang J.G., Owens A.P., Williams J., Antoniak S., Tencati M., et al. Hematopoietic and non-hematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood 2010, 116(5):806-814.
149. Pedersen B., Holscher T., Sato Y., Pawlinski R., Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood 2005, 105(7):2777-2782.
150. Pendurthi U.R., Allen K.E., Ezban M., Rao L.V. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction. The Journal of Biological Chemistry 2000, 275(19):14632-14641.
151. Pendurthi U.R., Alok D., Rao L.V. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: Up-regulation of poly(A) polymerase. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(23):12598-12603.
152. Penn M.S., Patel C.V., Cui M.Z., DiCorleto P.E., Chisolm G.M. LDL increases inactive tissue factor on vascular smooth muscle cell surfaces: Hydrogen peroxide activates latent cell surface tissue factor. Circulation 1999, 99(13):1753-1759.
153. Perez-Pujol S., Aras O., Lozano M., Cocking-Johnson D., Key N.S., White J.G., et al. Stored platelets contain residual amounts of tissue factor: Evidence from studies on platelet concentrates stored for prolonged periods. Transfusion 2005, 45(4):572-579.
154. Poulsen L.K., Jacobsen N., Sorensen B.B., Bergenhem N.C., Kelly J.D., Foster D.C., et al. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. The Journal of Biological Chemistry 1998, 273(11):6228-6232.
155. Ragni M., Cirillo P., Pascucci I., Scognamiglio A., D'Andrea D., Eramo N., et al. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation 1996, 93(10):1913-1918.
156. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A., et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000, 96(1):170-175.
157. Rehemtulla A., Ruf W., Edgington T.S. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. The Journal of Biological Chemistry 1991, 266(16):10294-10299.
158. Riewald M., Ruf W. Orchestration of coagulation protease signaling by tissue factor. Trends in Cardiovascular Medicine 2002, 12(4):149-154.
159. Rottingen J.A., Enden T., Camerer E., Iversen J.G., Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. The Journal of Biological Chemistry 1995, 270(9):4650-4660.
160. Sambola A., Osende J., Hathcock J., Degen M., Nemerson Y., Fuster V., et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003, 107(7):973-977.
161. Sato Y., Asada Y., Marutsuka K., Hatakeyama K., Sumiyoshi A. Tissue factor induces migration of cultured aortic smooth muscle cells. Thrombosis and Haemostasis 1996, 75(3):389-392.
162. Sato Y., Kataoka H., Asada Y., Marutsuka K., Kamikubo Y., Koono M., et al. Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor/factor VIIa complex. Thrombosis Research 1999, 94(6):401-406.
163. Scarpati E.M., Wen D., Broze G.J., Miletich J.P., Flandermeyer R.R., Siegel N.R., et al. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 1987, 26(17):5234-5238.
164. Schecter A.D., Giesen P.L., Taby O., Rosenfield C.L., Rossikhina M., Fyfe B.S., et al. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. The Journal of Clinical Investigation 1997, 100(9):2276-2285.
165. Schecter A.D., Spirn B., Rossikhina M., Giesen P.L., Bogdanov V., Fallon J.T., et al. Release of active tissue factor by human arterial smooth muscle cells. Circulation Research 2000, 87(2):126-132.
166. Schober J.M., Chen N., Grzeszkiewicz T.M., Jovanovic I., Emeson E.E., Ugarova T.P., et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): Immediate-early gene products expressed in atherosclerotic lesions. Blood 2002, 99(12):4457-4465.
167. Shoji M., Hancock W.W., Abe K., Micko C., Casper K.A., Baine R.M., et al. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. The American Journal of Pathology 1998, 152(2):399-411.
168. Siddiqui F.A., Desai H., Amirkhosravi A., Amaya M., Francis J.L. The presence and release of tissue factor from human platelets. Platelets 2002, 13(4):247-253.
169. Siegbahn A. Cellular consequences upon factor VIIa binding to tissue factor. Haemostasis 2000, 30(Suppl. 2):41-47.
170. Siegbahn A., Johnell M., Rorsman C., Ezban M., Heldin C.H., Ronnstrand L. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Blood 2000, 96(10):3452-3458.
171. Singh R., Pan S., Mueske C.S., Witt T., Kleppe L.S., Peterson T.E., et al. Role for tissue factor pathway in murine model of vascular remodeling. Circulation Research 2001, 89(1):71-76.
172. Soejima H., Ogawa H., Yasue H., Kaikita K., Nishiyama K., Misumi K., et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999, 99(22):2908-2913.
173. Soejima H., Ogawa H., Yasue H., Suefuji H., Kaikita K., Tsuji I., et al. Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction. The American Journal of Cardiology 1996, 78(3):336-340.
174. St Pierre J., Yang L.Y., Tamirisa K., Scherrer D., De Ciechi P., Eisenberg P., et al. Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs. Arteriosclerosis, Thrombosis, and Vascular Biology 1999, 19(9):2263-2268.
175. Stahli B.E., Breitenstein A., Akhmedov A., Camici G.G., Shojaati K., Bogdanov N., et al. Cardiac glycosides regulate endothelial tissue factor expression in culture. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27(12):2769-2776.
176. Stahli B.E., Camici G.G., Steffel J., Akhmedov A., Shojaati K., Graber M., et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circulation Research 2006, 99(2):149-155.
177. Steffel J., Arnet C., Akhmedov A., Iseli S.M., Luscher T.F., Tanner F.C. Histamine differentially interacts with tumor necrosis factor-alpha and thrombin in endothelial tissue factor induction: The role of c-Jun NH2-terminal kinase. Journal of Thrombosis and Haemostasis 2006, 4(11):2452-2460.
178. Steffel J., Hermann M., Greutert H., Gay S., Luscher T.F., Ruschitzka F., et al. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation 2005, 111(13):1685-1689.
179. Steffel J., Latini R.A., Akhmedov A., Zimmermann D., Zimmerling P., Luscher T.F., et al. Rapamycin, but not FK-506, increases endothelial tissue factor expression: Implications for drug-eluting stent design. Circulation 2005, 112(13):2002-2011.
180. Steffel J., Luscher T.F., Tanner F.C. Tissue factor in cardiovascular diseases: Molecular mechanisms and clinical implications. Circulation 2006, 113(5):722-731.
181. Stegenga M.E., van der Crabben S.N., Levi M., de Vos A.F., Tanck M.W., Sauerwein H.P., et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 2006, 55(6):1807-1812.
182. Stephens A.C., Rivers R.P. Suppression of human monocyte tissue factor synthesis by antisense oligodeoxynucleotide. Thrombosis Research 1997, 85(5):387-398.
183. Sturk-Maquelin K.N., Nieuwland R., Romijn F.P., Eijsman L., Hack C.E., Sturk A. Pro- and non-coagulant forms of non-cell-bound tissue factor in vivo. Journal of Thrombosis and Haemostasis 2003, 1(9):1920-1926.
184. Szotowski B., Antoniak S., Poller W., Schultheiss H.P., Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circulation Research 2005, 96(12):1233-1239.
185. Takano S., Tsuboi K., Tomono Y., Mitsui Y., Nose T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. British Journal of Cancer 2000, 82(12):1967-1973.
186. Taubman M.B., Marmur J.D., Rosenfield C.L., Guha A., Nichtberger S., Nemerson Y. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. The Journal of Clinical Investigation 1993, 91(2):547-552.
187. Taylor F.B., Chang A., Ruf W., Morrissey J.H., Hinshaw L., Catlett R., et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circulatory Shock 1991, 33(3):127-134.
188. ten Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis. Critical Care Medicine 2000, 28(Suppl. 9):S9-S11.
189. Thiruvikraman S.V., Guha A., Roboz J., Taubman M.B., Nemerson Y., Fallon J.T. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Laboratory Investigation; A Journal of Technical Methods and Pathology 1996, 75(4):451-461.
190. Toomey J.R., Kratzer K.E., Lasky N.M., Stanton J.J., Broze G.J. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996, 88(5):1583-1587.
191. Tsopanoglou N.E., Andriopoulou P., Maragoudakis M.E. On the mechanism of thrombin-induced angiogenesis: Involvement of alphavbeta3-integrin. American Journal of Physiology-Cell Physiology 2002, 283(5):C1501-1510.
192. Tsopanoglou N.E., Papaconstantinou M.E., Flordellis C.S., Maragoudakis M.E. On the mode of action of thrombin-induced angiogenesis: Thrombin peptide, TP508, mediates effects in endothelial cells via alphavbeta3 integrin. Thrombosis and Haemostasis 2004, 92(4):846-857.
193. Tutar E., Ozcan M., Kilickap M., Gulec S., Aras O., Pamir G., et al. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation 2003, 108(13):1581-1584.
194. Vaidyula V.R., Rao A.K., Mozzoli M., Homko C., Cheung P., Boden G. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2006, 55(1):202-208.
195. Versteeg H.H., Hoedemaeker I., Diks S.H., Stam J.C., Spaargaren M., van Bergen En Henegouwen P.M., et al. Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac. The Journal of Biological Chemistry 2000, 275(37):28750-28756.
196. Viswambharan H., Ming X.F., Zhu S., Hubsch A., Lerch P., Vergeres G., et al. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase. Circulation Research 2004, 94(7):918-925.
197. Wada H., Kaneko T., Wakita Y., Minamikawa K., Nagaya S., Tamaki S., et al. Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages. International Journal of Cardiology 1994, 47(Suppl. 1):S21-S25.
198. Wilcox J.N., Smith K.M., Schwartz S.M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proceedings of the National Academy of Sciences of the United States of America 1989, 86(8):2839-2843.
199. Wolberg A.S., Monroe D.M., Roberts H.R., Hoffman M.R. Tissue factor de-encryption: Ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagulation & Fibrinolysis 1999, 10(4):201-210.
200. Wu J., Stevenson M.J., Brown J.M., Grunz E.A., Strawn T.L., Fay W.P. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: Mechanisms and in vivo significance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28(4):698-704.
201. Wysokinski W.E., Owen W.G., Fass D.N., Patrzalek D.D., Murphy L., McBane R.D. Atrial fibrillation and thrombosis: Immunohistochemical differences between in situ and embolized thrombi. Journal of Thrombosis and Haemostasis 2004, 2(9):1637-1644.
202. Zhang Y., Deng Y., Luther T., Muller M., Ziegler R., Waldherr R., et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. The Journal of Clinical Investigation 1994, 94(3):1320-1327.
203. Zhang J.J., Kelm R.J., Biswas P., Kashgarian M., Madri J.A. PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells. Journal of Cellular Physiology 2007, 210(2):527-537.
204. Zillmann A., Luther T., Muller I., Kotzsch M., Spannagl M., Kauke T., et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochemical and Biophysical Research Communications 2001, 281(2):603-609.
205. Zioncheck T.F., Roy S., Vehar G.A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. The Journal of Biological Chemistry 1992, 267(6):3561-3564.
206. Zoldhelyi P., Chen Z.Q., Shelat H.S., McNatt J.M., Willerson J.T. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(7):4078-4083.